PRESS RELEASE published on 07/13/2026 at 21:20, 2 months 4 days ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook Evotec SE announces preliminary second quarter and first half 2026 results, updates full-year 2026 outlook. Key factors include revenue shift to 2027, strategic partnership delays, and base business momentum Evotec SE Preliminary Results Full-year Outlook Revenue Shift Base Business Momentum
PRESS RELEASE published on 07/13/2026 at 21:17, 2 months 4 days ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook Evotec SE announces preliminary second quarter and first half 2026 results and updates full-year 2026 outlook, reflecting adjusted financial figures and revised guidance Evotec SE Preliminary Results Financial Figures Full-year Outlook Revised Guidance
BRIEF published on 06/30/2026 at 07:35, 2 months 17 days ago Evotec AG Introduces J.TRAIN for Efficient Biologics Manufacturing Productivity Cost Efficiency Biologics Continuous Manufacturing J.TRAIN
PRESS RELEASE published on 06/30/2026 at 07:30, 2 months 17 days ago Just – Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics Evotec SE introduces J.TRAIN, a turnkey continuous manufacturing solution for biologics, enabling faster deployment and increased productivity. The model combines modular infrastructure, equipment, and technology for efficient capacity increase Technology Evotec SE Biologics Continuous Manufacturing J.TRAIN
BRIEF published on 06/11/2026 at 15:35, 3 months 6 days ago Evotec Announces Outcomes of 2026 Annual General Meeting Annual General Meeting Drug Discovery Evotec SE Supervisory Board Shareholder Voting
PRESS RELEASE published on 06/11/2026 at 15:30, 3 months 6 days ago Evotec Reports Results of the Annual General Meeting 2026 Evotec SE reports the results of its 2026 Annual General Meeting, including newly elected Supervisory Board members and voting outcomes. For more details, visit their website Annual General Meeting Shareholders Voting Results Evotec SE Supervisory Board
BRIEF published on 06/02/2026 at 07:35, 3 months 15 days ago Evotec Appoints Rui Wang as Head of Global In Silico and AI Drug Discovery Evotec SE AI In Pharma Rui Wang In Silico Innovation
PRESS RELEASE published on 06/02/2026 at 07:30, 3 months 15 days ago Evotec Appoints Rui Wang as Head of Global In Silico and AI Evotec SE appoints Rui Wang as Head of Global In Silico and AI, bringing over 20 years of experience in enterprise data and AI strategies for pharmaceutical and biotechnology operations Biotechnology AI Pharmaceutical Evotec Rui Wang
BRIEF published on 05/12/2026 at 22:30, 4 months 4 days ago Evotec SE Raises €116.1 Million through Convertible Bonds Frankfurt Stock Exchange Convertible Bonds Evotec SE Long-term Growth Project Horizon
PRESS RELEASE published on 05/12/2026 at 22:25, 4 months 4 days ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds Evotec SE successfully placed €116.1 million convertible bonds with a maturity of seven years at a 2.625% interest rate, aiming to strengthen the Company's operating model Investor Relations Convertible Bonds Financial News Evotec SE Corporate Action
Published on 09/17/2026 at 15:55, 6 hours 7 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 6 hours 37 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 7 hours 2 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 7 hours 2 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 7 hours 12 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 3 hours 2 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 3 hours 3 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 3 hours 37 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 3 hours 52 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 4 hours 16 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 4 hours 22 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 4 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 15 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification